IGFBP6 regulates extracellular vesicles formation via cholesterol abundance in MDA-MB-231 cells

• Published in: Biochimie 2024-12, Vol.227 (Pt A), p.77-85
• Main Authors: Shkurnikov, Maxim, Averinskaya, Darya, Stekolshchikova, Elena, Serkina, Anna, Razumovskaya, Alexandra, Silkina, Maria, Antipenko, Ivan, Makarova, Julia, Evtushenko, Ekaterina, Nikulin, Sergey, Tonevitsky, Alexander
• Format: Article
• Language: English
• Subjects: Breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cell Line, Tumor; Cholesterol - metabolism; Extracellular vesicles; Extracellular Vesicles - metabolism; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; IGF2; IGFBP6; Insulin-Like Growth Factor Binding Protein 6 - genetics; Insulin-Like Growth Factor Binding Protein 6 - metabolism; MDA-MB-231 Cells; Recurrence
• ISSN: 0300-9084; 1638-6183; 1638-6183
• DOI: 10.1016/j.biochi.2024.06.011

Breast cancer recurrence is associated with the growth of disseminated cancer cells that separate from the primary tumor before surgical treatment and hormonal therapy and form a metastatic niche in distant organs. We previously demonstrated that IGFBP6 expression is associated with the risk of early relapse of luminal breast cancer. Knockdown of IGFBP6 in MDA-MB-231 breast cancer cells increased their invasiveness, proliferation, and metastatic potential. In addition, the knockdown of IGFBP6 leads to impaired lipid metabolism. In this study, we demonstrated that the knockdown of the IGFBP6 gene, a highly selective inhibitor of IGF-II, led to a significant decline in the number of secreted extracellular vesicles (EVs) and altered cholesterol metabolism in MDA-MB-231 cells. Knockdown of IGFBP6 led to a decrease in the essential proteins responsible for the biogenesis of cholesterol LDLR and LSS, which reduced the amount by more than 13 times. In addition, the knockdown of IGFBP6 led to a possible change in the profile of adhesion molecules on the surface of EVs. The expression of L1CAM, IGSF3, EpCAM, CD24, and CD44 decreased, and the expression of EGFR increased. We can conclude that the negative prognostic value of low expression of this gene could be associated with increased activity of IGF2 in tumor-associated fibroblasts due to low secretion of IGFBP6 by tumor cells. In addition, changing the profile of adhesion molecules on the surface of tumor EVs may contribute to the more efficient formation of metastatic niches. •IGFBP6 regulates extracellular vesicles formation.•Knockdown of IGFBP6 led to a decrease in the proteins responsible for the biogenesis of cholesterol.•IGFBP6 decrease may led to a change in adhesion molecules on the surface of EVs.